Aprea Therapeutics, Inc. (NASDAQ:APRE) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| John B Henneman III Other companies: Orthofix Medical Inc. (Director · Since at least Jan 5, 2023); Anika Therapeutics Inc. (Director · Since at least Sep 3, 2020); R1 RCM Inc (Director · Apr 3, 2017 – Nov 19, 2024 · Past); Accretive Health Inc (Director · Feb 16, 2016 – Jan 3, 2017 · Past); SeaSpine Holdings Corp (Director · Jul 1, 2015 – Jan 5, 2023 · Past); Lumos Pharma Inc (Chief Administrative Officer · Oct 1, 2014 – Oct 1, 2018 · Past); Integra LifeSciences Holdings Corporation (CorpVP, CAO · Jan 6, 2006 – Aug 25, 2014 · Past) | Director · Since at least Oct 2, 2019 |
| Michael A. Kelly Other companies: Prime Medicine, Inc. (Board Member · Since at least Oct 19, 2022); Amicus Therapeutics Inc (Director · Since at least Dec 1, 2020); DMC Global Inc. (Director · Since at least Jul 24, 2020); NeoGenomics, Inc. (Board Member · Since at least Jul 15, 2020); Hookipa Pharma Inc (Director · Apr 17, 2019 – Jun 30, 2022 · Past) | Director · Sep 28, 2020 – Jun 30, 2021 · Past |
| Scott M Rocklage Other companies: Pulmatrix, Inc. (Director · Jun 15, 2015 – Feb 3, 2016 · Past); Cidara Therapeutics Inc (Director · Apr 14, 2015 – Jun 13, 2018 · Past); EPIRUS Biopharmaceuticals Inc (Director · Jul 15, 2014 – Jun 5, 2015 · Past); Achaogen Inc (Director · Mar 11, 2014 – Mar 11, 2014 · Past); Relypsa Inc (Director · Nov 14, 2013 – Nov 20, 2013 · Past) | Director · Oct 2, 2019 – Jun 30, 2020 · Past |
| Christian S. Schade Other companies: Integra LifeSciences Holdings Corporation (Director · Since at least May 17, 2006); Omega Therapeutics Inc (Director · Jul 10, 2023 – Jun 20, 2024 · Past); Omthera Pharmaceuticals Inc (Executive VP and CFO · Apr 11, 2013 – Jul 16, 2013 · Past); NRG Energy, Inc. (Exec VP & Chief Financial Ofc · Mar 29, 2010 – Mar 29, 2011 · Past) | Director · Oct 2, 2019 – Jul 28, 2022 · Past |
| Jean-Pierre Bizzari Other companies: ADC Therapeutics SA (Non-Executive Director · Since at least Jan 2, 2024); Palvella Therapeutics, Inc. (Director · Jun 29, 2015 – Jan 25, 2020 · Past); Celator Pharmaceuticals Inc (Director · Feb 27, 2015 – Jul 12, 2016 · Past); Halozyme Therapeutics, Inc. (Director · Jan 17, 2015 – May 5, 2023 · Past) | Director · Since at least Aug 23, 2023 |
| Michael Grissinger Other companies: Lipocine Inc. (Director · Since at least Aug 3, 2026); Adicet Bio, Inc. (Director · Since at least Nov 5, 2018); Akari Therapeutics PLC (Director · Jan 1, 2024 – Jun 28, 2024 · Past) | Director · Since at least May 16, 2022 |
| Bernd R. Seizinger Other companies: Oncolytics Biotech Inc. (Director · Since at least Jan 1, 2026); Aptose Biosciences Inc (Director · Sep 13, 2022 – Feb 5, 2024 · Past) | Director · Since at least Oct 2, 2019 |
| Eugene Kennedy Other companies: Galera Therapeutics, Inc. (Chief Medical Officer · Sep 1, 2022 – Feb 25, 2023 · Past); Lumos Pharma Inc (Chief Medical Officer · Nov 13, 2017 – Feb 1, 2021 · Past) | Chief Medical Advisor · Since at least Oct 16, 2026 |
| Fouad Namouni Other companies: Vor Biopharma Inc. (Chair of the Nominating and Corporate Governance Committee · Since at least Apr 30, 2024); Blueprint Medicines Corp (PRESIDENT, R & D · Since at least Sep 1, 2020) | Director · Jun 26, 2020 – Jun 30, 2021 · Past |
| Gabriela Gruia Other companies: TScan Therapeutics, Inc. (Director · Since at least Jul 15, 2021); Molecular Templates Inc (Director · Mar 1, 2022 – Sep 27, 2024 · Past) | Director · Since at least May 5, 2023 |
| John P. Hamill Other companies: Windtree Therapeutics, Inc. (SVP & CFO · Jul 20, 2020 – Jul 26, 2022 · Past); Trevena, Inc. (VP Fin,Princ Fin&Acct Officer · May 31, 2019 – May 31, 2019 · Past) | Senior Vice President and Chief Financial Officer · Since at least Jan 30, 2023 |
| Richard Peters Other companies: Kineta Inc. (Director · Since at least Dec 22, 2020); Merrimack Pharmaceuticals Inc (President and CEO, Director · May 8, 2019 – May 8, 2019 · Past) | Director · Since at least Jun 26, 2020 |
| Brian Wiley Other companies: Lumos Pharma Inc (Chief Commercial Officer · Jan 2, 2013 – Mar 9, 2018 · Past) | Senior Vice President of Corporate Development & Strategy · Since at least Nov 4, 2026 |
| Eyal C Attar Other companies: Vor Biopharma Inc. (CHIEF MEDICAL OFFICER · Oct 11, 2022 – Feb 13, 2025 · Past) | SVP, Chief Medical Officer, Director · Oct 2, 2019 – Jun 3, 2022 · Past |
| Guido Magni Other companies: Adolor Corp (Director · Jun 6, 2008 – Dec 7, 2011 · Past) | Director · Oct 2, 2019 – Oct 7, 2019 · Past |
| Scott Coiante Other companies: Lexicon Pharmaceuticals, Inc. (Senior Vice President and Chief Financial Officer · Since at least Jan 2, 2025) | SVP, Chief Financial Officer · Oct 2, 2019 – Jul 28, 2022 · Past |
| Gregory Alan Korbel | SVP, Chief Operating Officer · Oct 2, 2019 – Jul 28, 2022 · Past |
| Gregory S Wessels | SVP, Chief Commercial Officer · Sep 16, 2020 – Feb 25, 2021 · Past |
| John B. Henneman | Director · Since at least Jun 17, 2026 |
| Jonathan Hepple | Director · Oct 2, 2019 – Jun 30, 2020 · Past |
| Lars B Abrahmsen | SVP, Chief Scientific Officer · Oct 2, 2019 – Mar 10, 2022 · Past |
| Marc Duey | Director · Since at least May 16, 2022 |
| Nadeem Q Mirza | Chief Medical Officer · May 1, 2024 – May 1, 2024 · Past |
| Oren Gilad | President and Chief Executive Officer · Since at least Mar 13, 2024 |
| Rifat Pamukcu | Director · Since at least May 16, 2022 |
| Ze’ev Weiss | Chief Business Advisor · Since at least Nov 4, 2026 |